Trump signs order threatening up to 100% tariffs on pharmaceuticals

President Trump signed an executive order Thursday imposing pharmaceutical tariffs that could reach as high as 100% unless drugmakers agree to pricing negotiations with his administration. Trump framed the move as tied to national security concerns, expanding his broader trade strategy beyond traditional goods. The tariffs could significantly disrupt global pharmaceutical supply chains and potentially increase drug costs for American consumers and healthcare systems. The order essentially leverages tariff threats as leverage to force price concessions from drugmakers, marking an aggressive shift in how the Trump administration is approaching medication affordability. The move signals Trump's willingness to use trade policy as a tool for broader economic objectives beyond traditional protectionism.